AR024472A1 - Inhibidores de la integrina alfav beta6. - Google Patents
Inhibidores de la integrina alfav beta6.Info
- Publication number
- AR024472A1 AR024472A1 ARP000103177A ARP000103177A AR024472A1 AR 024472 A1 AR024472 A1 AR 024472A1 AR P000103177 A ARP000103177 A AR P000103177A AR P000103177 A ARP000103177 A AR P000103177A AR 024472 A1 AR024472 A1 AR 024472A1
- Authority
- AR
- Argentina
- Prior art keywords
- ala
- asp
- arg
- phe
- gly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19929410A DE19929410A1 (de) | 1999-06-26 | 1999-06-26 | Inhibitoren des Integrins avß6 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR024472A1 true AR024472A1 (es) | 2002-10-02 |
Family
ID=7912712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000103177A AR024472A1 (es) | 1999-06-26 | 2000-06-23 | Inhibidores de la integrina alfav beta6. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1189930A1 (ko) |
| JP (1) | JP2003503422A (ko) |
| KR (1) | KR20020015704A (ko) |
| CN (1) | CN1358195A (ko) |
| AR (1) | AR024472A1 (ko) |
| AU (1) | AU771099B2 (ko) |
| BR (1) | BR0011954A (ko) |
| CA (1) | CA2377224A1 (ko) |
| CZ (1) | CZ20014484A3 (ko) |
| DE (1) | DE19929410A1 (ko) |
| HU (1) | HUP0201729A3 (ko) |
| MX (1) | MXPA01013247A (ko) |
| NO (1) | NO20016341L (ko) |
| PL (1) | PL352374A1 (ko) |
| SK (1) | SK18722001A3 (ko) |
| WO (1) | WO2001000660A1 (ko) |
| ZA (1) | ZA200200673B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| AU2004208865B2 (en) | 2003-02-06 | 2010-06-17 | Merck Patent Gmbh | Peptidic sulfonamides |
| GB0520068D0 (en) | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
| KR20090039739A (ko) | 2006-08-03 | 2009-04-22 | 아스트라제네카 아베 | αＶβ６에 대해 작용하는 항체 및 그의 용도 |
| KR102634762B1 (ko) * | 2016-11-01 | 2024-02-06 | 애로우헤드 파마슈티컬스 인코포레이티드 | 알파-v 베타-6 인테그린 리간드 및 그의 용도 |
| KR20200083523A (ko) | 2017-11-01 | 2020-07-08 | 애로우헤드 파마슈티컬스 인코포레이티드 | 인테그린 리간드 및 그의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2103139A1 (en) * | 1991-05-14 | 1992-11-15 | George A. Heavner | Peptide inhibitors of inflammation |
| US20020004482A1 (en) * | 1997-08-08 | 2002-01-10 | Xiaozhu Huang | Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| CN1335853A (zh) * | 1998-12-19 | 2002-02-13 | 默克专利股份公司 | 整联蛋白αvβb的抑制剂 |
-
1999
- 1999-06-26 DE DE19929410A patent/DE19929410A1/de not_active Withdrawn
-
2000
- 2000-06-13 SK SK1872-2001A patent/SK18722001A3/sk unknown
- 2000-06-13 CA CA002377224A patent/CA2377224A1/en not_active Abandoned
- 2000-06-13 EP EP00949177A patent/EP1189930A1/de not_active Withdrawn
- 2000-06-13 WO PCT/EP2000/005404 patent/WO2001000660A1/de not_active Application Discontinuation
- 2000-06-13 BR BR0011954-7A patent/BR0011954A/pt not_active IP Right Cessation
- 2000-06-13 AU AU62630/00A patent/AU771099B2/en not_active Ceased
- 2000-06-13 HU HU0201729A patent/HUP0201729A3/hu unknown
- 2000-06-13 KR KR1020017016580A patent/KR20020015704A/ko not_active Application Discontinuation
- 2000-06-13 JP JP2001507066A patent/JP2003503422A/ja active Pending
- 2000-06-13 CZ CZ20014484A patent/CZ20014484A3/cs unknown
- 2000-06-13 MX MXPA01013247A patent/MXPA01013247A/es unknown
- 2000-06-13 CN CN00809493A patent/CN1358195A/zh active Pending
- 2000-06-13 PL PL00352374A patent/PL352374A1/xx unknown
- 2000-06-23 AR ARP000103177A patent/AR024472A1/es not_active Application Discontinuation
-
2001
- 2001-12-21 NO NO20016341A patent/NO20016341L/no not_active Application Discontinuation
-
2002
- 2002-01-24 ZA ZA200200673A patent/ZA200200673B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL352374A1 (en) | 2003-08-25 |
| JP2003503422A (ja) | 2003-01-28 |
| DE19929410A1 (de) | 2000-12-28 |
| ZA200200673B (en) | 2003-04-24 |
| CA2377224A1 (en) | 2001-01-04 |
| SK18722001A3 (sk) | 2002-05-09 |
| CZ20014484A3 (cs) | 2002-04-17 |
| HUP0201729A2 (en) | 2002-08-28 |
| NO20016341L (no) | 2002-02-25 |
| CN1358195A (zh) | 2002-07-10 |
| HUP0201729A3 (en) | 2005-01-28 |
| AU6263000A (en) | 2001-01-31 |
| KR20020015704A (ko) | 2002-02-28 |
| WO2001000660A1 (de) | 2001-01-04 |
| BR0011954A (pt) | 2002-05-07 |
| EP1189930A1 (de) | 2002-03-27 |
| AU771099B2 (en) | 2004-03-11 |
| NO20016341D0 (no) | 2001-12-21 |
| MXPA01013247A (es) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR039231A1 (es) | Agentes de union ox40r novedosos | |
| NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
| CY1105616T1 (el) | ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1 | |
| ES2160485B1 (es) | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. | |
| ATE477020T1 (de) | Prevention und verringerung von ischemia | |
| CY1110927T1 (el) | Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων | |
| DE60331546D1 (de) | Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung | |
| ATE171712T1 (de) | Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten | |
| DE69009476T2 (de) | Hemmung des reaktionswegs für die n-ende-regel in lebenden zellen. | |
| AR024472A1 (es) | Inhibidores de la integrina alfav beta6. | |
| MXPA02000465A (es) | Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6. | |
| ATE443076T1 (de) | Von protease typ ii spaltbares peptid | |
| US20080171697A1 (en) | Peptides Having For Example Antiangiogenic Activity and Applications Thereof In Therapeutics | |
| ES2058873T3 (es) | Antagonistas peptidicos sinteticos de neuroquinina a, sus sales y procedimientos de preparacion respectivos. | |
| AR020101A1 (es) | Un antagonista peptido del receptor de uroquinasa humana, composicion farmaceutica que lo contiene, su uso para la manufactura de un medicamento y metodopara seleccionar un antagonista peptido adecuado. | |
| NO20034146L (no) | Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase | |
| DE60120507D1 (de) | Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 | |
| TH57872B (th) | สารยับยั้งของอินทีกริน อัลฟานู เบตา6 | |
| DE60331166D1 (de) | Splice variante des menschlichen hypophysären wachstumshormons | |
| ATE438660T1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
| RU2022104944A (ru) | Рекомбинантная плазмида pBSU-ANQ, обеспечивающая синтез рекомбинантного химерного белка, включающего фрагмент ангиогенина человека | |
| TH56074A3 (th) | ตัวยับยั้ง อัลฟาv เบตา6 อินทีกริน | |
| ES2119746T3 (es) | Nuevo peptido fisiologicamente activo y agente regulador del metabolismo del calcio que comprende dicho peptido como ingrediente activo. | |
| TH56074B (th) | ตัวยับยั้ง (อัลฟาv เบตา6) อินทีกริน | |
| LT2004079A (en) | Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |